ENDS 2020 – Dedicated to the Electronic Nicotine Delivery Systems Industry
Europe’s leading e-cigarette conference looking at scientific, commercial and regulatory aspects, will this year be held in Brussels on the 13th and 14th of May. Dedicated to the e-cig industry, the conference covers all topics related to scientific, commercial and regulatory matters pertaining ENDS, such as the latest regulations (including TPD) and research to testing methods, concerns and standards, product design, potential harm reduction and more. Besides delegates from the vaping industry, attending the conference there will be interested parties from other industries such as testing companies, Big Tobacco, regulatory and legislative bodies, law firms and more. This creates an opportunity and a platform for dialogue and exchange of information.
Wednesday, February 26, 2020
Coronavirus in China may mean global shortages for vaping manufacturers
The novel coronavirus (COVID-19) that has so far killed more than 2600 people in China has had limited impact up to now in the vaping industry around the world, but severe movement restrictions have led to fears of disruption.
Dimitris Agrafiotis, executive director of the Tennessee Smoke-Free Association and chief executive of Global eVapor Consulting, has found cause to worry about supply chain disruptions.
Tuesday, February 25, 2020
Philip Morris drew up plan for £1bn tobacco transition fund
Philip Morris International [...] drew up plans for a £1bn tobacco transition fund in the UK to be spent by local authorities and Public Health England on persuading smokers to give up cigarettes in favour of alternatives such as its “heat not burn” smokeless tobacco product, IQOS, leaked documents reveal. PMI wants to be seen as part of the solution to smoking, which kills half of all people who take it up, even though the company continues to make and market cigarettes around the world. Deborah Arnott, chief executive of Action on Smoking and Health (Ash), said this approach was “breathtakingly hypocritical”.
Wednesday, February 19, 2020
Retraction to: Electronic Cigarette Use and Myocardial Infarction Among Adults in the US Population Assessment of Tobacco and Health
After becoming aware that the study in the above‐referenced article did not fully account for certain information in the Population Assessment of Tobacco and Health [PATH] Wave 1 survey, the editors of Journal of the American Heart Association reviewed the peer review process. During peer review, the reviewers identified the important question of whether the myocardial infarctions occurred before or after the respondents initiated e‐cigarette use, and requested that the authors use additional data in the PATH codebook (age of first MI and age of first e‐cigarettes use) to address this concern. While the authors did provide some additional analysis, the reviewers and editors did not confirm that the authors had both understood and complied with the request prior to acceptance of the article for publication.
Wednesday, February 19, 2020
American Heart Association Journal Finally Retracts Study Implying That E-Cigarettes Cause Heart Attacks Before People Use Them
Eight months after the Journal of the American Heart Association published a study implying that e-cigarettes magically cause heart attacks before people even try them, it has retracted the article. (...) Notwithstanding the evidence that vaping is much less hazardous than smoking, Glantz and Bhatta, an epidemiologist at the center, concluded that "e‐cigarettes should not be promoted or prescribed as a less risky alternative to combustible cigarettes and should not be recommended for smoking cessation among people with or at risk of myocardial infarction." But as University of Louisville tobacco researcher Brad Rodu pointed out last July, the analysis that Bhatta and Glantz ran included former smokers who had heart attacks before they started vaping. Once those subjects were excluded, Rodu and University of Louisville economist Nantaporn Plurphanswat found, the association described by (...)
Tuesday, February 18, 2020
Patients Who Smoke at Risk of Problems During Surgery
Patients who smoke tobacco are likely to experience more complications with anaesthesia during operation compared to non-smokers, says a report by World Health Organisation. According to the international health agency, tobacco smokers are at a significantly higher risk than non-smokers of post-surgical complications, including impaired heart and lung functions, infections and delayed or impaired wound healing. The joint study by WHO and University of Newcastle, shows that the nicotine and carbon monoxide, both present in cigarettes, can decrease oxygen levels and greatly increase the risk of heart-related complications after surgery. “Smoking tobacco also damages the lungs, making it difficult for the proper amount of air to flow through, increasing the risk of post-surgical complications to the lungs,” says the study.